Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000384

Type of data
NGS (RNA-seq, Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
682 GB
File formats
  • FASTQ
  • BAM
Research
hum0251
Date published
2022-11-29
Date modified
2022-11-29
DDBJ Search
JGAD000384 (opens in a new tab)
JGA Study
JGAS000278 (opens in a new tab)

Unrestricted-access files linked to this dataset

Download the URL list
FileLabelSizeCopy URL
hum0251_gene_list.xlsx110 genes10.7 KB

Analysis method

RNA-seq

Materials and participants
Ph-negative B-ALL (ICD10: C91.0): 122 cases
  • Health status
    Affected
  • Subject count
    122 (Individual)
  • Age group
    Adult
Disease
Ph-negative B-ALL (C910)
Sample description
RNA extracted from leukemia cells
  • Tissue
    Leukemia cell
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext Ultra Directional RNA Library Prep Kit for Illumina
Fragmentation
Heat treatment
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
125 bp
Data use policy
NBDC data sharing policy (JGAP000001)

Targeted DNA sequencing

Materials and participants
Ph-negative B-ALL (ICD10: C91.0): 148 cases
  • Health status
    Affected
  • Subject count
    148 (Individual)
  • Age group
    Adult
Disease
Ph-negative B-ALL (C910)
Sample description
DNA extracted from leukemia cells
  • Tissue
    Leukemia cell
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
110 genes
Reagent kit
SureSelect XT Low Input
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
125 bp
Reference genome
GRCh37
Mapping
bwa
Mapping quality
> 20
Coverage (depth)
570x
Data use policy
NBDC data sharing policy (JGAP000001)